PaxMedica
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PaxMedica and buy or sell other stocks, ETFs, and their options commission-free!About PXMD
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis.
CEOHoward J. Weisman
CEOHoward J. Weisman
Employees5
Employees5
HeadquartersTarrytown, New York
HeadquartersTarrytown, New York
Founded2018
Founded2018
Employees5
Employees5
PXMD Key Statistics
Market cap8.60K
Market cap8.60K
Price-Earnings ratio-0.09
Price-Earnings ratio-0.09
Dividend yield—
Dividend yield—
Average volume11.11M
Average volume11.11M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.07
52 Week high$4.07
52 Week low$0.1471
52 Week low$0.1471
Stock Snapshot
As of today, PaxMedica(PXMD) shares are valued at $0.00. The company's market cap stands at 8.6K, with a P/E ratio of -0.09.
On 2026-04-04, PaxMedica(PXMD) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for PaxMedica(PXMD) stock has reached 0, versus its average volume of 11.11M.
The stock's 52-week range extends from a low of $0.15 to a high of $4.07.
The stock's 52-week range extends from a low of $0.15 to a high of $4.07.
People also own
Based on the portfolios of people who own PXMD. This list is generated using Robinhood data, and it’s not a recommendation.